2012•Unpublished venueRequires access

Figure 71, Impact of injectable low molecular weight heparin versus oral or injectable direct thrombin inhibitors on pulmonary embolism in patients undergoing major orthopedic surgery limited to trials published from 2001 to the present

Diana M Sobieraj, Craig Ian Coleman, Vanita Tongbram, Soyon Lee, Jennifer A. Colby, Wendy T Chen, Sagar S Makanji, Ajibade O. Ashaye, Jeffrey Kluger, C Michael White

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Pulmonary embolism, Orthopedic surgery, Heparin, Low molecular weight heparin, Surgery, Clinical trial, Rivaroxaban

Back to paper search Browse research topics Original source

Figure 71, Impact of injectable low molecular weight heparin versus oral or injectable direct thrombin inhibitors on pulmonary embolism in patients undergoing major orthopedic surgery limited to trials published from 2001 to the present — Research Paper | ScholarLens